Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Work In Process (2019 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Work In Process for 7 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Work In Process rose 60.82% to $4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.5 million, a 60.82% increase, with the full-year FY2024 number at $2.8 million, up 80.03% from a year prior.
  • Work In Process was $4.5 million for Q3 2025 at Xtant Medical Holdings, up from $3.4 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.5 million in Q3 2025 to a low of $571000.0 in Q4 2021.
  • A 5-year average of $1.8 million and a median of $1.5 million in 2021 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: crashed 67.05% in 2021, then soared 95.74% in 2023.
  • Xtant Medical Holdings' Work In Process stood at $571000.0 in 2021, then skyrocketed by 39.75% to $798000.0 in 2022, then skyrocketed by 95.74% to $1.6 million in 2023, then soared by 80.03% to $2.8 million in 2024, then soared by 61.27% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Work In Process are $4.5 million (Q3 2025), $3.4 million (Q2 2025), and $3.0 million (Q1 2025).